Theravance, Inc. · South San Francisco, CA United States (NASDAQ: THRX)
Key Theravance, Inc. Financials
| Company Type | Public -(NASDAQ: THRX) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $24.2 |
| 2010 Employees | 193 |
Theravance, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 24.2 | 24.4 | 23.1 |
| Cost of Goods Sold | 0.0 | 0.0 | -- |
| Gross Profit | 24.2 | 24.4 | 23.1 |
| Gross Profit Margin | 100% | 100% | -- |
| SG&A Expense | 27.5 | 27.1 | 28.9 |
| Depreciation & Amortization | 6.3 | 5.5 | 7.0 |
| Operating Income | (78.3) | (81.4) | (93.2) |
| Operating Margin | -323.3% | -333.8% | -403.6% |
| Nonoperating Income | -- | -- | -- |
| Nonoperating Expenses | (5.5) | (3.9) | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (83.9) | (85.3) | (93.6) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (83.9) | (85.3) | (93.6) |
| Total Net Income | (83.9) | (85.3) | (93.6) |
| Net Profit Margin | -346.2% | -350% | -405.5% |
| Diluted EPS from Total Net Income | (1.16) | (1.35) | (1.53) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Theravance, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 163.3 | 47.5 | 92.3 |
| Net Receivables | 0.7 | 0.4 | 0.6 |
| Inventories | -- | -- | -- |
| Other Current Assets | 152.3 | 114.1 | 117.1 |
| Total Current Assets | 316.4 | 162.0 | 210.0 |
| Net Fixed Assets | 10.2 | 12.9 | 16.2 |
| Other Noncurrent Assets | 4.6 | 6.4 | 10.0 |
| Total Assets | 331.2 | 181.4 | 236.2 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 2.1 | 1.8 | 3.3 |
| Short-Term Debt | 0.2 | 0.2 | 0.1 |
| Other Current Liabilities | 37.7 | 37.0 | 40.6 |
| Total Current Liabilities | 40.1 | 38.9 | 44.0 |
| Long-Term Debt | 172.6 | 172.8 | 172.8 |
| Other Noncurrent Liabilities | 141.0 | 158.7 | 154.3 |
| Total Liabilities | 353.6 | 370.4 | 371.1 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | -- |
| Common Stock Equity | (22.4) | (189.0) | (134.9) |
| Total Equity | (22.4) | (189.0) | (134.9) |
| Shares Outstanding (thou.) | 80,352.0 | 64,232.0 | 61,845.8 |
All amounts in millions of US Dollars except per share amounts.
Theravance, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | (75) | (58) | (100) |
| Net Investing Cash Flow | (40.3) | 1.7 | (67.4) |
| Net Financing Cash Flow | 231.2 | 11.6 | 173.1 |
| Net Change in Cash | 115.8 | (44.7) | 5.8 |
| Depreciation & Amortization | 6.3 | 5.5 | 7.0 |
| Capital Expenditures | (0.9) | (0.7) | (1.0) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.